FindTrial
Sign In

Cumulative network-meta-analyses, practice guidelines and real-world prescriptions of drug treatments for post-menopausal osteoporosis

Cumulative network-meta-analyses, practice guidelines and real-world prescriptions of drug treatments for post-menopausal osteoporosis - Cumulative network-meta-analyses, practice guidelines and real-world prescription

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000031894
Enrollment
500
Registered
2018-04-01
Start date
2018-12-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-menopausal osteoporosis

Interventions

None listed

Sponsors

Department of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: post-menopausal osteoporois

Exclusion criteria

Exclusion criteria: Rheumatoid arthritis and related disease Chronic renal failure Cancer

Design outcomes

Primary

MeasureTime frame
Ranking of drugs to treat post-menopausal osteoporosis by means of cumulative network meta-analysis. Ranking of recommended post-menopausal osteoporosis in clinical practice guidelines in America. Ranking of actual prescriptions based on MEPS.—

Countries

Japan,North America,Europe

Contacts

Public ContactYuki Kataoka

Hyogo Prefectural Amagasaki General Medical Center Hospital Care Research Unit

youkiti@gmail.com+81664807000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026